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The capacity of the immune system in infants to develop stable T-cell memory in response to vaccination is
attenuated, and the mechanism(s) underlying this developmental deficiency in humans is poorly understood.
The present study focuses on the capacity for expression of in vitro recall responses to tetanus and diphtheria
antigens in lymphocytes from 12-month-old infants vaccinated during the first 6 months of life. We demon-
strate that supplementation of infant lymphocytes with “matured” dendritic cells (DC) cultured from autol-
ogous CD14 precursors unmasks previously covert cellular immunity in the form of Th2-skewed cytokine
production. Supplementation of adult lymphocytes with comparable prematured autologous DC also boosted
vaccine-specific T-cell memory expression, but in contrast to the case for the infants, these cytokine responses
were heavily Th1 skewed. Compared to adults, infants had significantly fewer circulating myeloid DC (P <
0.0001) and plasmacytoid DC (P < 0.0001) as a proportion of peripheral blood mononuclear cells. These
findings suggest that deficiencies in the numbers of antigen-presenting cells and their functional competence
at 12 months of age limit the capacity to express effector memory responses and are potentially a key factor in
reduced vaccine responsiveness in infants.
Morbidity and mortality resulting from infectious diseases
are inversely related to age, and the development of more
effective vaccines for use in the highest-risk age group (infants)
represents a major unmet need. Current practices associated
with immunological evaluation of potential vaccines prior to
their widespread release rely principally on assessment of vac-
cine-specific immunological memory development within the
humoral compartment, restricted in the main to immunoglob-
ulin G (IgG) antibody titers. However, an increasing body of
evidence suggests that humoral immunity following vaccina-
tion does not necessarily equate directly with protection, with
a notable example being resistance to pertussis (3, 8). A variety
of animal (21, 24) and human (3) studies have highlighted the
potentially important role of cellular immunity, in the form of
cytokine production by vaccine-primed CD4 T-memory cells,
in vaccine-induced host resistance. However, assessment of the
efficacy of vaccines in inducing cellular immune memory is not
widely utilized in vaccine evaluation.
A complicating factor in this equation is the generalized
functional immaturity of the immune system in human neo-
nates and its relatively slow and highly variable kinetics of
maturation over the first few years of life (13, 26, 35). This
functional attenuation in early life is manifest particularly in
the Th1 arm of the adaptive immune response, with genes such
as that for gamma interferon (IFN-) displaying highly re-
stricted patterns of expression in response to a variety of stim-
uli (1, 4, 27, 37), and in some situations this skewing may
compromise the capacity to develop stable protective immunity
following vaccination and/or to resist primary infections (5, 14,
26).
The mechanism(s) underlying the diminished capacity of the
infant immune system to develop efficient sterilizing immunity
is only partially understood. The available evidence suggests
that the maturational defect is multifactorial and involves
mechanisms intrinsic to the T-cell system and also within an-
tigen-presenting cells (APC) of the immune system (6, 9, 10,
30, 33). With respect to the T-cell compartment, recent studies
implicate hypermethylation of CpG motifs in the proximal
promoter of the IFN- gene as a major factor limiting expres-
sion of Th1 immunity (39), especially in the early postnatal
period (15, 36). However, information relating to the nature of
the functional deficiency in APC during early life is more
limited and is generally restricted to studies of cord blood APC
(6, 9, 10, 30, 33). Much less is known concerning APC function
during the postnatal period, an issue that may become espe-
cially relevant as maternal antibodies disappear. In particular,
there is no direct information on the relationship between the
functional status of APC populations in humans and the ca-
pacity to express cellular immunity following vaccination in the
first few years of life.
Detailed mechanistic studies examining this issue are diffi-
cult to perform because only small volumes of blood can be
obtained from young children. In the current prospective
study, we addressed whether the capacity to develop in vitro
recall responses of peripheral blood mononuclear cells
(PBMC) to diphtheria toxoid or tetanus toxoid in 12-month-
old infants vaccinated at 2, 4, and 6 months is limited by
circulating APC. Having samples of cryobanked cord blood
cells from these children made it possible to supplement
PBMC cultures with autologous, “matured” dendritic cells
(DC), leading to a marked increase in cytokine responses and
revealing the presence of covert T-cell reactivity that was not
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detectable in parallel PBMC cultures without additional DC.
The numbers of peripheral blood plasmacytoid DC and my-
eloid DC were reduced at 12 months of age relative to those in
adults, suggesting that deficits in the number and function of
circulating APC are likely to be key factors in reduced vaccine
responsiveness in infants.
MATERIALS AND METHODS
Subjects. Healthy infants (n  48) were recruited into a prospective study on
development of immune function in early life. All children were born at term
(37 weeks of gestation) following a normal pregnancy. Blood samples were
collected from the umbilical cord at birth and from a peripheral vein at 12
months of age. Adult blood samples were obtained from healthy laboratory
volunteers (n  32) who had all received booster vaccinations against diphtheria
and tetanus during adolescence or early adult life. This study was carried out with
the approval of the Princess Margaret Hospital Research and Ethics Committee.
Informed consent was obtained from all adult subjects and from the parents or
guardians of the children.
Sample collection and cell preparation. Blood samples were collected into an
equal volume of RPMI 1640 (Invitrogen-Life Technologies, Melbourne, Austra-
lia) containing preservative-free heparin (20 U/ml). PBMC were isolated by
density gradient centrifugation and cryopreserved in liquid nitrogen, as previ-
ously described (18). Cryobanked cord blood samples were necessary for the
critical experiments employing PBMC cocultured with autologous DC (as de-
scribed below), so all experiments were therefore performed using cryopreserved
cells. Previous studies from our laboratory and elsewhere have demonstrated
that this procedure does not distort cellular immune responses (3, 12, 18), nor
does it influence the generation of DC from neonatal and adult monocytes
cultured with granulocyte-macrophage colony-stimulating factor (GM-CSF) and
interleukin-4 (IL-4) (35). For functional studies, PBMC that had been cryopre-
served were thawed and resuspended at 106 viable cells/ml in RPMI 1640 sup-
plemented with L-glutamine, 5% pooled human AB serum (BioWhittaker Inc.,
Maryland), 2-mercaptoethanol (4  105 M; Sigma-Aldrich Co., Sydney, Aus-
tralia), and gentamicin (Pharmacia Australia Pty. Ltd., Sydney, Australia), here-
after referred to as complete medium.
Antigen-specific T-cell responses. PBMC (2  105 cells) were cultured in
round-bottom 96-well plates (Nunc) in 200 l of complete medium. Cells were
cultured alone or with optimal stimulatory concentrations of diphtheria toxoid
(0.5 Limes flocculation [Lf]/ml) or tetanus toxoid (0.5 Lf/ml). Both antigens were
obtained from CSL Ltd., Melbourne, Australia, and dialyzed against phosphate-
buffered saline to remove preservatives. Levels of cytokine protein in culture
supernatant were measured at 48 h after the initiation of cultures, and all data
were expressed as “delta” values, designating levels of cytokine synthesis above
those in unstimulated control cultures.
In some experiments, PBMC were cultured in the presence of autologous
monocyte-derived DC (2  104 cells per well, i.e., a PBMC/DC ratio of 10:1).
Initial experiments with adults compared DC cultured with either unseparated
PBMC or purified T cells; no significant difference in antigen-specific lympho-
proliferation or cytokine synthesis was observed. Accordingly, experiments there-
after employed PBMC without further T-cell enrichment.
Generation of relatively mature DC from peripheral blood and cord blood.
Adult monocyte-derived DC were prepared from peripheral blood monocytes by
using methods described previously (35). Because only small volumes of blood
(typically 1 to 2 ml) were available from 12-month-old children, insufficient cells
with which to generate DC directly were available, so DC were derived instead
from cryobanked, autologous cord blood monocytes (n  9). Briefly, monocytes
(90% CD14) were isolated by negative selection using anti-CD2, -CD7,
-CD16, -CD56, -CD19, and -glycophorin A antibodies, followed by anti-mouse
immunomagnetic beads (Dynal Biotech Australia, Melbourne, Australia), and
cultured for 7 days in the presence of 50 ng/ml GM-CSF (Leukomax; Schering-
Plough, Sydney, Australia) and 20 ng/ml IL-4 (Chemicon Australia Pty. Ltd.,
Melbourne, Australia). Every 2 or 3 days, fresh medium, GM-CSF, and IL-4
were added. After 7 days of culture, nonadherent cells corresponding to the
DC-enriched fraction were harvested, washed, and used for subsequent experi-
ments. These cells contained over 90% DC as determined by morphology, the
presence of HLA-DR, and the absence of CD14 expression. These DC expressed
intermediate levels of HLA-DR and CD86 and were therefore more mature than
circulating DC, but they still had the capacity to further increase their expression
of HLA-DR and CD86 in response to lipopolysaccharide (LPS) in vitro (data not
shown). However, for experiments examining T-cell responses to antigens,
monocyte-derived DC were not stimulated with LPS.
Flow cytometric analysis. For immunophenotyping, cells were washed in PBS
supplemented with 0.1% sodium azide and 1% normal human serum and incu-
bated for 30 min on ice with one of the following monoclonal antibodies (MAbs)
(all obtained from BD Biosciences, Sydney, Australia): fluorescein isothiocya-
nate (FITC)-conjugated CD14, FITC-conjugated annexin V, propidium iodide,
peridinin chlorophyll protein-conjugated HLA-DR, and allophycocyanin-conju-
gated CD4. Corresponding isotype-matched control MAbs were also used. Cells
were analyzed immediately using a FACSCalibur flow cytometer with CellQuest
software (Becton Dickinson).
For enumeration of DC subsets, cells were stained with a commercial four-
color antibody kit (BD Biosciences) containing lineage-specific antibodies con-
jugated to FITC (a cocktail of MAbs specific for B cells, T cells, monocytes, and
NK cells), CD123-phycoerythrin, HLA-DR–PerCp, and CD11c-allophycocyanin.
Circulating DC were defined as “lineage-negative” cells expressing HLA-DR and
further divided into plasmacytoid and myeloid subsets based on differential
expression of CD123 (plasmacytoid DC) and CD11c (myeloid DC). At least
150,000 mononuclear cells were acquired on the flow cytometer in order to
obtain sufficient numbers of DC subsets for accurate enumeration, and the
results are expressed as percentages of mononuclear cells.
Detection of IL-5, IL-13, and IFN-. The levels of cytokine protein in culture
supernatants were determined by time-resolved fluorometry, using antibody
pairs obtained from BD Biosciences, as described in detail elsewhere (28).
Standard curves were generated using serial dilutions of recombinant IL-5,
IL-13, and IFN- (BD Biosciences, Sydney, Australia). For detection, europium-
labeled streptavidin (Delfia Wallac, Finland) was added, followed by enhance-
ment solution (Delfia Wallac). The detection limits of the assays were 10 pg/ml
for IL-5, 3 pg/ml for IL-13, and 20 pg/ml for IFN-.
Statistical analyses. Group data were expressed as means and 95% confidence
intervals. Data concerning numbers of DC subsets were normally distributed, so
comparisons between infants and adults were analyzed with the unpaired t test.
All other comparisons between groups were analyzed with the Wilcoxon signed
rank test for paired data and the Mann-Whitney U test for unpaired data. All
analyses were performed with SPSS version 11 for Macintosh (SPSS Inc., Chi-
cago, Illinois).
RESULTS
Vaccine-specific cytokine responses. We first examined the
expression of vaccine-specific T-cell memory in nine healthy
12-month-old children from whom sufficient numbers of cells
were available both at birth and at 12 months of age. All the
children in the study had received cellular diphtheria-tentanus-
pertussis (whole-cell pertussis) vaccine immunization with
alum at 2, 4, and 6 months of age, and sera from all subjects
contained significant titers of vaccine-specific IgG against both
diphtheria and tetanus antigens (data not shown). However,
T-cell memory (detectable as cytokine production by PBMC
exposed to tetanus toxoid and diphtheria toxoid) was small
(Fig. 1A), with positive cytokine responses detectable in only a
minority of individuals (Fig. 1C). Supplementation of vaccine
antigen-stimulated PBMC cultures with autologous “matured”
DC unmasked previously covert IFN-, IL-5, and IL-13 re-
sponses to both tetanus toxoid and diphtheria toxoid in all nine
subjects (Fig. 1A). In contrast, cord PBMC did not respond to
these vaccine antigens, even when cocultured with autologous
“matured” DC (Fig. 1B). Given that in utero exposure to
tetanus toxoid and diphtheria toxoid is extremely unlikely, this
lack of response in the cord PBMC/DC cocultures suggests
that the responses seen at 12 months were not due to nonspe-
cific stimulation by DC but rather reflect antigen-specific re-
call.
Vaccine-specific T-cell memory was also examined in
healthy adult laboratory volunteers (n  23). PBMC responses
to tetanus toxoid and diphtheria toxoid were detectable in the
majority of adults, and the magnitude of individual cytokine
responses was much higher than that in the 12-month-old chil-
dren (Fig. 2A and B). The addition of autologous DC further
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increased the magnitude of the adult PBMC responses (Fig.
2A) but had only a minor (statistically nonsignificant) effect on
the proportion of adults in whom a positive cytokine response
could be detected (Fig. 2B).
While DC supplementation augmented PBMC responses to
vaccine antigens in adults, important quantitative and qualita-
tive differences were seen compared to the effects of DC sup-
plementation in 12-month-old children. In DC-supplemented
cultures, IFN- production was considerably higher than IL-13
or IL-5 production in adults (Fig. 2A), whereas levels of IFN-,
IL-13, and IL-5 production were similar in 12-month-old chil-
dren (Fig. 1A). The major difference between DC-supple-
FIG. 1. Effects of DC supplementation on vaccine-specific cytokine production in infants and newborns. (A and B) PBMC from 12-month-old
children (A) and newborns (cord blood) (B) were cultured for 48 h with diphtheria toxoid (diptox) or tetanus toxoid (tettox) in the presence or
absence of additional autologous DC. Data are expressed as  values, designating levels of cytokine production above those in unstimulated control
cultures. Error bars indicate 95% confidence intervals. (C) Percentages of subjects with positive cytokine responses to vaccine antigens. The data
shown in panel A were analyzed in order to show the percentage of 12-month-old children manifesting at least one detectable cytokine response
(whether IFN-, IL-5, or IL-13) following in vitro stimulation with diphtheria toxoid or tetanus toxoid. *, P	 0.05; **, P	 0.005 (Wilcoxon signed
rank test).
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mented cultures from adults and from 12-month-old children
was the markedly higher IFN- production seen in adults.
Similar levels of the Th2 cytokines IL-13 and IL-5 were ob-
served in both adults and children. As shown in Table 1, IFN-
/IL-5 and IFN-/IL-13 ratios were high in adults but low in
12-month-old children. Thus, cytokine response patterns in
DC-supplemented cultures were strongly Th1 skewed in adults
but were unpolarized or even Th2 skewed in 12-month-old
children.
Further examination of PBMC cultures showed that reduced
cell survival was a prominent feature in 12-month-old children
but not in adults, as shown in Fig. 3. Antigen stimulation of
PBMC from the infants led to a significant increase in the
number of annexin-V-positive apoptotic CD4 T cells (Fig. 3,
top), whereas antigen stimulation did not significantly affect
CD8 T-cell apoptosis (data not shown). Similar results were
obtained with diphtheria toxoid (data not shown). Addition of
autologous matured DC reduced apoptosis in PBMC from
12-month-old children by approximately 50% (Fig. 3, top), but
had no effect on the low levels of apoptosis seen in adult
cultures.
These findings suggested that there might be quantitative or
FIG. 2. Effects of DC supplementation on vaccine-specific cytokine production in adults. PBMC from adults (n  23) were cultured for 48 h
with diphtheria toxoid (diptox) or tetanus toxoid (tettox) in the presence or absence of additional autologous DC. (A) Data are expressed as 
values, designating levels of cytokine production above those in unstimulated control cultures. Error bars indicate 95% confidence intervals.
(B) Percentages of subjects with positive cytokine responses to vaccine antigens. The data shown in panel A were analyzed in order to show the
percentage of subjects manifesting at least one detectable cytokine response following in vitro stimulation with diphtheria toxoid or tetanus toxoid.
*, P 	 0.05; **, P 	 0.005 (Wilcoxon signed rank test).
TABLE 1. Vaccine antigen-specific Th1/Th2 ratios in PBMC-DC cocultures from 12-month-old children and adults
Ratio
Median (interquartile range)a
12-mo-old children Adults
Diphtheria toxoid Tetanus toxoid Diphtheria toxoid Tetanus toxoid
IFN-/IL-5 0.2 (0.1–1.0) 0.4 (0.1–1.6) 55.2b (3.6–196.5) 25.8b (2.3–40.3)
IFN-/IL-13 0.4 (0.1–1.7) 0.1 (0.0–1.2) 19.9c (1.5–32.5) 6.8b (1.7–18.1)
a The IFN-/IL-5 and IFN-/IL-13 ratios were calculated for each individual. The statistical significance of differences between 12-month-old children and adults was
assessed using the Mann-Whitney U test.
b P  0.001 compared to value for 12-month-old children.
c P  0.004 compared to value for 12-month-old children.
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qualitative deficiencies in circulating APC in 12-month-old
children compared to those in adults. Myeloid DC and plas-
macytoid DC are thought to be the principal APC in the
peripheral blood, and as shown in Fig. 4, both these subsets
were significantly less numerous at 12 months than in adult life
(P 	 0.0001 for both DC subsets). The expression of HLA-DR
on these DC subsets at 12 months was less intense than that on
adult DC subsets (data not shown). Numbers of monocytes
were similar in 12-month-old children and adults (data not
shown).
DISCUSSION
The risk of serious infection is particularly high during in-
fancy, and there is a need to better understand the determi-
nants of host protection at this age, especially the mechanisms
regulating development of stable immune memory directed
against pathogenic microbes. Increasing interest in the deter-
minants of cellular immunity directed against vaccine antigens
led us to reexamine the role of APC maturity in this context.
Previous research in this area has highlighted the potential
importance of APC maturation as a determinant of the effi-
ciency of the initial priming process in T-cell memory devel-
opment. We demonstrate here for the first time in humans
that, independent of steps during priming, the numbers of
circulating APC and their functional competence may also
determine the capacity to express effector memory responses
(notably cellular immunity in the form of cytokine production)
after the priming process is complete.
Our laboratory has previously shown for a prospective co-
hort of healthy children that the capacity to mount Th1 cyto-
kine responses to vaccine antigens often remains low until
beyond the age of 12 months (26). Similar findings are evident
in the present study, in which we demonstrated that when
PBMC from fully vaccinated 12-month-old children were cul-
tured with diphtheria and tetanus antigens, cytokine responses
were often small or below the threshold of detection. This
finding is difficult to reconcile with the fact that 100% of cellular
diphtheria-tetanus-pertussis (whole-cell pertussis) vaccine-
primed 12-month-old infants in this study demonstrated vac-
cine-specific IgG antibody in peripheral blood, production of
which is dependent on T-helper cell activity. Accordingly, ei-
ther relevant T-helper memory cells do not recirculate in these
infants or the culture system used to reactivate them (viz.,
whole PBMC plus vaccine antigen) is in some way deficient for
this purpose, and the results of this study are compatible with
the latter explanation. Thus, when PBMC cultures were sup-
plemented with autologous cord blood monocytes that had
been differentiated into DC by using GM-CSF and IL-4, a
different picture of T-cell memory emerged. Supplementation
with these relatively mature, antigen-presenting DC markedly
increased cytokine responses to both diphtheria toxoid and
tetanus toxoid and, in many cases, revealed the presence of
covert T-cell reactivity that was undetectable in parallel PBMC
cultures. These findings suggest that the minimal T-cell reac-
tivity in PBMC cultures derived from vaccine-primed infants at
12 months is not entirely due to the low frequency of vaccine-
specific memory T cells in the peripheral circulation but rather
that the capacity to reactivate specific T cells is also con-
strained by endogenous, circulating APC populations.
As shown in Fig. 4, the numbers of peripheral blood myeloid
DC and plasmacytoid DC relative to PBMC were significantly
reduced in 12-month-old children compared to adults. Because
FIG. 3. Effects of DC supplementation on CD4 T-cell apoptosis
by tetanus toxoid-stimulated PBMC from 12-month-old children (n 
7) and adults (n  7). Using flow cytometry, apoptotic CD4 T cells
were identified as annexin V-positive, propidium iodide-positive cells
and the data expressed as a percentage of total PBMC. Ag, antigen.
Error bars indicate 95% confidence intervals. a, P 0.009; b, P 0.02;
c, P  0.012 (Wilcoxon signed rank test).
FIG. 4. Enumeration of DC subsets in 12-month-old children (n 
48) and adults (n 32). Using flow cytometry, myeloid DC (mDC) and
plasmacytoid DC (pDC) were enumerated and expressed as a percent-
age of PBMC. Error bars indicate 95% confidence intervals. ***, P 	
0.0001 (12-month-old children versus adults, unpaired t test).
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of the nature of the specimen collection in this prospective
study, it was not possible to measure absolute numbers of DC
subsets per microliter of blood. However, we did not observe
any differences in the numbers of other cell populations be-
tween adults and 12-month-old children, making it likely that
these changes in differential cell counts reflect changes in ab-
solute cell numbers. This is supported by reports showing dif-
ferences in the absolute numbers of blood DC subsets in young
children compared to older children and adults (11, 31). Sim-
ilar reductions in DC numbers within mucosal tissue in early
life have also been reported (23, 34).
Over and above the low numbers of blood DC at 12 months,
it is likely that there are additional deficits in APC function at
this age. Blood DC are functionally immature at birth relative
to their adult counterparts (29) and continue to express a less
differentiated surface phenotype during most of early child-
hood (11), while the capacity to synthesize IL-12, a key APC-
derived cytokine, matures quite slowly during childhood (35).
Even though the small volumes of blood available at 12 months
precluded a detailed assessment of the function of purified DC
subsets, the reduced expression of HLA-DR on myeloid and
plasmacytoid DC is consistent with an immature phenotype,
making it likely that both deficiencies of APC function and
reduction in numbers of DC subsets combine to retard the
expression of T-cell memory at this age.
It is noteworthy that DC supplementation boosted vaccine-
specific T-cell reactivity in both adults and 12-month-old chil-
dren, suggesting that the APC populations present in the pe-
ripheral circulation at all ages do not express full functional
capacity. This is not unexpected, given the comprehensive lit-
erature indicating that in healthy animals the only sites at
which fully mature APC (in particular DC) are present consti-
tutively are primary lymphoid organs or sites of chronic immu-
noinflammatory lesions. The system employed to generate DC
produces cells with APC activity that is comparable to that in
the latter case, and our findings may thus reflect potential for
in vivo responsiveness to vaccine antigens more accurately than
the picture seen with conventional PBMC culture systems.
Despite the similarities in overall DC-mediated augmenta-
tion of vaccine-specific recall responses, the ensuing patterns
of cytokine production varied markedly with age. Whereas
IL-13 and IL-5 responses were similar in infants and adults,
IFN- responses in the infants remained considerably below
those observed in adults, a finding that is in broad agreement
with the large body of murine studies showing that relative
Th1/Th2 response patterns vary significantly with age. In par-
ticular, while infection or immunization during the neonatal
period triggers transient Th1 and Th2 cytokine production,
subsequent T-cell memory is largely Th2 polarized, whereas
infection or immunization in adult animals induces Th1-polar-
ized immunity (1, 5). Of particular note, we have demonstrated
previously that Th1 memory responses to acellular diphtheria-
tetanus-pertussis (acellular pertussis) vaccine are unstable dur-
ing late infancy relative to the Th2 component, with the former
requiring maturation of as-yet-undefined elements of systemic
immune function to enable stable expression of T-cell memory
that was primed during the first 6 months of life (26, 27). The
relative inability to develop stable Th1 memory in early child-
hood has been variously attributed to intrinsic properties of T
cells (2) or to deficiencies in APC function (25, 33), especially
their capacity to secrete polarizing cytokines such as IL-12 (9,
10, 16, 35).
Our findings suggest that even in the presence of apparently
mature antigen-presenting DC, there remains a relative defi-
ciency in Th1 memory expression in childhood (Fig. 1 and 2
and Table 1). This may be due in part to the predilection of
immature T cells to undergo apoptotic death following activa-
tion, as shown in Fig. 3, confirming previous work from our
laboratory and others (17, 32). It is noteworthy that while
introduction of mature autologous DC into these cultures
markedly reduced T-cell attrition, the levels of overall cell loss
in the infant cultures still remained approximately threefold
higher than those observed in adults. Th1 effector cells appear
to be more susceptible than Th2 effector cells to apoptosis
following antigen stimulation in adult mice (38, 40), a situation
that may be exaggerated during infancy (17), thereby contrib-
uting to the relative inability to develop stable Th1 memory, as
discussed above. We have shown previously that antigen-in-
duced apoptosis of cord blood T cells can be inhibited by IL-2,
IL-4, and IL-7 (32), although whether these cytokines mediate
the effects shown in Fig. 3 or whether additional mechanisms
specific to DC are involved was not examined in the current
study. It will be important for future research to examine the
relative importance of T-cell apoptosis as a factor limiting
vaccine responsiveness in infancy, using caspase inhibitors, for
example.
It is clear that T-cell responses in infancy are both attenu-
ated and intrinsically Th2 skewed relative to those in adults.
However, while mature DC were able to augment the expres-
sion of vaccine-specific T-cell memory seen in infant PBMC
cultures, mature DC were unable to overcome the Th2 skewing
of infant responses and unleash the high-level IFN- responses
seen in the adult cultures. Goriely and coworkers have previ-
ously shown that neonatal monocyte-derived DC exhibit im-
paired IL-12 p35 transcription in response to LPS compared
with adult DC (9, 10), although addition of IFN- allows neo-
natal DC to secrete adult-equivalent amounts of bioactive
IL-12 p70 (9, 10, 35). Neonatal CD4 cells also appear to be
intrinsically deficient in their capacity to express Th1 effector
function (2), a characteristic that can be partially attributed to
hypermethylation within and adjacent to the IFN- promoter
(36).
The clinical implication of these observations is that optimal
induction of vaccine-specific T-cell memory in early childhood
may require the use of strategies designed specifically to com-
pensate for deficiencies in the number and/or function of APC.
Antigen challenge together with adjuvants that up-regulate
APC function allows neonatal animals to mount relatively ma-
ture Th1 responses (7, 20, 22), while mycobacterial vaccines
with intrinsic adjuvant properties can induce vigorous IFN-
responses in human infants (19). Accordingly, it appears that
the deficiencies of APC function in young children are not
immutable, as APC can be induced to mature via the provision
of appropriate microenvironmental signals, whether these are
adjuvants or cytokines with the capacity to induce DC matu-
ration in vivo. More-detailed studies are required to elucidate
the relationship between postnatal maturation of DC function
and variations in the capacity to induce protective immunity, as
a foundation on which to develop new vaccines strategies for
use during infancy.
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